These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 22452231)
1. The role of cytological evaluation of pleural fluid in diagnosing malignant mesothelioma. Lovrenski A; Panjković M; Tegeltija D; Latinović LT; Krcedinac J Med Pregl; 2012; 65(1-2):5-8. PubMed ID: 22452231 [TBL] [Abstract][Full Text] [Related]
2. The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Rakha EA; Patil S; Abdulla K; Abdulkader M; Chaudry Z; Soomro IN Diagn Cytopathol; 2010 Dec; 38(12):874-9. PubMed ID: 20049969 [TBL] [Abstract][Full Text] [Related]
3. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma. Ylagan LR; Zhai J Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis and prognosis in malignant pleural mesothelioma: a prospective study. Mårtensson G; Hagmar B; Zettergren L Eur J Respir Dis; 1984 Apr; 65(3):169-78. PubMed ID: 6723826 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology. Canessa PA; Franceschini MC; Ferro P; Battolla E; Dessanti P; Manta C; Sivori M; Pezzi R; Fontana V; Fedeli F; Pistillo MP; Roncella S Cancer Invest; 2013 Jan; 31(1):43-50. PubMed ID: 23249166 [TBL] [Abstract][Full Text] [Related]
12. Cytologic re-evaluation of negative effusions from patients with malignant mesothelioma. Ascoli V; Bosco D; Carnovale Scalzo C Pathologica; 2011 Dec; 103(6):318-24. PubMed ID: 22558888 [TBL] [Abstract][Full Text] [Related]
13. [Pleural mesothelioma--case with effusion in both pleural cavities]. Fijałkowski M; Jochymski C Pol Merkur Lekarski; 2004 Nov; 17(101):479-82. PubMed ID: 15754636 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma. Hiraki A; Aoe K; Murakami T; Nakamura Y; Yamazaki K; Sueoka N; Taguchi K; Kamei T; Maeda T; Takeyama H; Kishimoto T; Nishimura M; Sugi K Oncol Rep; 2005 Aug; 14(2):357-62. PubMed ID: 16012715 [TBL] [Abstract][Full Text] [Related]
15. Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers. Henderson DW; Reid G; Kao SC; van Zandwijk N; Klebe S J Clin Pathol; 2013 Oct; 66(10):847-53. PubMed ID: 23814259 [TBL] [Abstract][Full Text] [Related]
16. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis. Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350 [TBL] [Abstract][Full Text] [Related]
17. [Localized fibrous mesothelioma with bloody pleural effusion; report of a case]. Ogata K; Sakakibara K; Hirano R; Nishiumi N; Tsutsumi M; Ishihara S; Namikawa S Kyobu Geka; 2004 Feb; 57(2):159-62. PubMed ID: 14978915 [TBL] [Abstract][Full Text] [Related]
18. [Clinical comparison of diffuse malignant mesothelioma of the pleura and pseudomesotheliomatous carcinoma of the lung for each case]. Yuasa H; Tomoyasu M Kyobu Geka; 1999 Sep; 52(10):836-9. PubMed ID: 10478545 [TBL] [Abstract][Full Text] [Related]
19. [Chronic pleuropathy due to asbestos and malignant mesothelioma of the pleura: a differential diagnosis not always easy. A case report]. de Pangher Manzini V Recenti Prog Med; 1999 Jun; 90(6):331-3. PubMed ID: 10399473 [TBL] [Abstract][Full Text] [Related]
20. [The role of pleural effusion cytology in the diagnosis of malignancies]. Mermolja M; Debeljak A Plucne Bolesti; 1989; 41(3-4):146-9. PubMed ID: 2636394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]